SCHEMBL20369169

SCHEMBL20369169

C=CCSCC1Nc2cc(Cl)c(S(=O)(=O)NC(C)C)cc2S(=O)(=O)N1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 2/20 0.72
▸ CYP3A4 P08684 2/20 0.72
▸ KDM4E B2RXH2 1/20 0.72
▸ HPGD P15428 1/20 0.72
▸ ATM Q13315 1/20 0.72
▸ TDP1 Q9NUW8 1/20 0.48
▸ LMNA P02545 3/20 0.45
▸ ADRA2B P18089 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HTT P42858 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11929320 0.89 CYP3A4 (0.76) CYP2C9CYP3A4KDM4EHPGDATM
Althiazide SCHEMBL29388917 0.84 CYP3A4 (1.00) CYP2C9CYP3A4KDM4EHPGDATM
Althiazide SCHEMBL26514792 0.84 CYP3A4 (1.00) CYP2C9CYP3A4KDM4EHPGDATM
Althiazide SCHEMBL25992937 0.84 CYP3A4 (1.00) CYP2C9CYP3A4KDM4EHPGDATM
Althiazide SCHEMBL124525 0.84 CYP3A4 (1.00) CYP2C9CYP3A4KDM4EHPGDATM
SCHEMBL23721761 0.77 CYP2C9 (0.69) CYP2C9CYP3A4KDM4EHPGDATM
SCHEMBL11929014 0.75 LMNA (0.69) CYP2C9CYP3A4KDM4EHPGDATM
SCHEMBL20369162 0.74 LMNA (0.46) CYP2C9CYP3A4KDM4EHPGDATM
SCHEMBL10539700 0.72 KDM4E (0.73) CYP2C9CYP3A4KDM4EHPGDATM
Epithiazide SCHEMBL124824 0.68 CYP3A4 (0.71) CYP2C9CYP3A4KDM4EHPGDATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194732-A1 MULTI-API LOADING PRODRUGS JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194732-A1 MULTI-API LOADING PRODRUGS AADAC, PAICS, ABCG2 CYP2C9 30/4885CYP3A4 69/4885KDM4E 423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback